Continuous Subcutaneous Infusion of Compound Oxycodone for the Relief of Dyspnea in Patients With Terminally Ill Cancer
- 5 June 2012
- journal article
- clinical trial
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 30 (3) , 305-311
Abstract
Pain and dyspnea are the most prevalent and distressing symptoms in patients with terminally ill cancer. Evidences have accumulated for the effects of morphine on dyspnea, whereas little is known about the effects of oxycodone on dyspnea. We investigated the effectiveness of oxycodone for dyspnea in patients with terminally ill cancer. The injectable form of compound oxycodone (iOC) containing hydrocotarnine was administered continuously via subcutaneous route. We administered iOC to 136 patients. The effect on dyspnea was less conspicuous than pain, yet iOC was effective for dyspnea with varying degrees. None of the adverse effects observed were serious. These results suggest that continuous subcutaneous administration of oxycodone could be one of the reasonable alternatives in the management of dyspnea in patients with terminally ill cancer.Keywords
This publication has 21 references indexed in Scilit:
- The Use of Major Analgesics in Patients with Renal DysfunctionCurrent Drug Targets, 2010
- Effect of Hydrocotarnine on Cytochrome P450 and P-glycoproteinDrug Metabolism and Pharmacokinetics, 2009
- A Randomized Double-Blind Crossover Comparison of Continuous and Intermittent Subcutaneous Administration of Opioid for Cancer PainJournal of Palliative Medicine, 2008
- Oxycodone: a review of its use in the management of painCurrent Medical Research and Opinion, 2007
- Pharmacokinetics and Variation in the Clearance of Oxycodone and Hydrocotarnine in Patients with Cancer PainBiological and Pharmaceutical Bulletin, 2007
- OxycodoneJournal of Pain and Symptom Management, 2005
- Pain Measurement Tools and Methods in Clinical Research in Palliative CareJournal of Pain and Symptom Management, 2002
- Morphine and alternative opioids in cancer pain: the EAPC recommendationsBritish Journal of Cancer, 2001
- Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodoneJournal of Pain and Symptom Management, 1996
- Morphine and oxycodone hydrochloride in the management of cancer painClinical Pharmacology & Therapeutics, 1990